Financial statements Farmacore
Cash inflows of FARMACORE
|
Year
|
2022
|
2023
|
|---|---|---|
| Net cash from operating expenses | 44 899,00 | 37 193,00 |
| Net cash flow from investing activities | 12 207,00 | -6 534,00 |
| Net cash flow from financial activities | -56 827,00 | -30 030,00 |
| Total net cash flow | 279,00 | 629,00 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.